Sponsor · clinical trials

Hospices Civils de Lyon clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine and the EU Clinical Trials Information System (CTIS) — current trials in our France, Belgium, India, Israel, Germany, Egypt, Italy and EU (CTIS) registers with Hospices Civils de Lyon as lead sponsor. Synced 10 Nov 2026

387Current trials

264Recruiting now

36Drugs in these trials

8Trial registers

Maintained by Sreepriya Prasannan

MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist

Compiled from ClinicalTrials.gov and CTIS registry records · Synced 10 Nov 2026 · Editorial standards

At a glance

Hospices Civils de Lyon is the lead sponsor of 387 current clinical trials in our France, Belgium, India, Israel, Germany, Egypt, Italy and EU (CTIS) registers. 264 are recruiting patients now. The most common phase is Not applicable. The drugs named most often in its trials are Blood sampling, Biocollection and Blood sample. The most-studied condition is Epilepsy.

ClinicalTrials.gov trials by status

Recruiting26469%
Not yet open8923%
Active, closed298%

Trials by phase

Not applicable18147%
Observational17345%
Phase 2113%
Phase 382%
Phase 1/241%
Phase 431%
Phase 110%
Phase 2/310%

Clinical trials sponsored by Hospices Civils de Lyon

382 on ClinicalTrials.gov

Study	Phase	Status	Start	Registers
A Clinical and Biological Prospective Database of Patients Treated With Anticancer Immunotherapy and Follow up of Their Immune-related Adverse Events irAE NCT03989323 · ClinicalTrials.gov ↗ · Cancer	Observational	Recruiting	2019-07	France
Clinical and Social Trajectories of Children and Adolescents With Disruptive Behavior NCT02812537 · ClinicalTrials.gov ↗ · Disruptive Behavior Disorder	Observational	Recruiting	2019-05	France
Interferon Reference for Older People - REFIPA Study NCT07239830 · ClinicalTrials.gov ↗ · Immunosenescence, Uninfected Older	Not applicable	Recruiting	2025-12	France
Peer-Support Breastfeeding Program for Mothers in Severe Socioeconomic Deprivation: Feasibility Study NCT07499466 · ClinicalTrials.gov ↗ · Breastfeeding, Breastfeeding Support, Health Disparities	Observational	Recruiting	2025-12	France
Retrospective and Prospective Cohort of Patients Entering the Multidisciplinary Management of Post-Covid Syndromes NCT05805566 · ClinicalTrials.gov ↗ · Post-Covid Syndrome	Observational	Recruiting	2023-04	France
Carotid Atherosclerosis : Innovative Imaging Biomarkers. Study Case-control NCT02748941 · ClinicalTrials.gov ↗ · Carotid Stenosis	Not applicable	Recruiting	2017-01	France
Using an Intervention Adapted to the Health Literacy Level to Improve Adherence to Medical Recommendations NCT03951467 · ClinicalTrials.gov ↗ · Acute Decompensated Heart Failure, Acute Myocardial Infarction	Not applicable	Recruiting	2025-06	France
TOngue/Palate Interactions Study NCT03966131 · ClinicalTrials.gov ↗ · Toothless	Not applicable	Recruiting	2024-02	France
A Technical Innovation of Prismatic Adaptation Test in Healthy Subject, in Favour of Autonomy and Independence in Daily Life Following a Brain Injury NCT03807401 · ClinicalTrials.gov ↗ · Healthy Volunteers	Not applicable	Recruiting	2019-10	France
Validation of Biomarkers Performance to Reduce Antibiotics overUse in newBorns With Suspected Clinical Signs of InfectionS NCT06058819 · ClinicalTrials.gov ↗ · Neonatal Late Onset Sepsis	Observational	Recruiting	2023-11	France
Circadian Variation of Urinary Copper Excretion in Wilson Disease Patients NCT06430359 · ClinicalTrials.gov ↗ · Wilson Disease	Observational	Recruiting	2025-01	France
Optical Imaging in X-linked Disorders. NCT06868979 · ClinicalTrials.gov ↗ · Fragile X Syndrome (FXS), Creatine Transporter Deficiency	Not applicable	Recruiting	2026-03	France
Effects of Non-invasive Ventilation Therapies on the Lung in Hypoxemic Chest Trauma Patients NCT06735872 · ClinicalTrials.gov ↗ · Lung Trauma, Lung Contusion	Not applicable	Recruiting	2025-04	France
Efficiency of Everolimus for the Treatment of Kidney Transplanted Patients Presenting a Missing Self-induced NK-mediated Rejection NCT03955172 · ClinicalTrials.gov ↗ · Kidney Transplant Failure and Rejection Drug: Everolimus	Not applicable	Recruiting	2020-12	France
Developing a Complex ex Vivo Endometrial Tissue Model to Improve Endometriosis Care NCT06331676 · ClinicalTrials.gov ↗ · Endometriosis	Not applicable	Recruiting	2024-06	France
A PET-MRI Study of Serotoninergic Brainstem Pathway in Patients With Dravet Syndrome NCT07013331 · ClinicalTrials.gov ↗ · Epilepsy, Dravet Syndrome, Drug Resistant Epilepsy	Not applicable	Recruiting	2026-05	France
Predict Tooth Wear NCT06681844 · Prediction of Tooth Wear	Observational	Recruiting	2023-12	India, France, Belgium, Israel
Evaluate DF-003 in ex Vivo Assays Using Peripheral Blood Mononuclear Cell From Subjects With ROSAH Syndrome NCT05319132 · ClinicalTrials.gov ↗ · Unrecognized Condition	Observational	Recruiting	2022-09	France
Health-economic Assessment of Robot-assisted Bariatric Surgery NCT06858761 · ClinicalTrials.gov ↗ · Obesity	Not applicable	Recruiting	2025-07	France
CoHort of Patients to Identify Biological and Imaging markerS of CardiovascUlar Outcomes in Stroke - HIBISCUS-STROKE II NCT05263804 · ClinicalTrials.gov ↗ · Ischemic Stroke	Not applicable	Recruiting	2022-05	France
Compliance and Tolerance to Oral AntiBiotherapy in Osteoarticular Infections (OTABIO) NCT05202964 · ClinicalTrials.gov ↗ · Drug-Related Side Effects and Adverse Reactions, Treatment Adherence and Compliance	Observational	Recruiting	2024-06	France
Quality of Life and Fertility of Patient With Deep Surgical Endometriosis: a Prospective Cohort NCT03555903 · ClinicalTrials.gov ↗ · Deep Infiltrating Endometriosis	Observational	Recruiting	2018-05	France
Avis-PHAGEinLYON Clinic NCT05883995 · ClinicalTrials.gov ↗ · Bone Infection	Observational	Recruiting	2023-02	France
Early Deresuscitation Strategy Driven by Tissue Perfusion in Renal Replacement Therapy in Patients With Acute Renal Failure NCT05817539 · ClinicalTrials.gov ↗ · Acute Kidney Injury, Fluid Overload	Not applicable	Recruiting	2023-12	France
Influence of Oxidative Stress and Nutrition Biomarkers on the Cognitive Decline Evolution in Alzheimer Disease NCT02800395 · ClinicalTrials.gov ↗ · Alzheimer Disease	Not applicable	Recruiting	2014-12	France
Azathioprine in MOGAD NCT05349006 · ClinicalTrials.gov ↗ · Central Nervous System Inflammation, MOG-IgG Associated Disease Drug: Azathioprine	Phase 3	Recruiting	2023-12	France
Prodromes of Menstrual Staphylococcal Toxic Shock NCT06124599 · ClinicalTrials.gov ↗ · Toxic Shock Syndrome Staphylococcal	Observational	Recruiting	2021-12	France
Probiotic Intervention for Digestive Health in Obese Patients Initiating GLP-RA Treatment NCT07213323 · ClinicalTrials.gov ↗ · Obesity &Amp; Overweight, Digestive Disorders	Not applicable	Recruiting	2026-08	France
Biological Collection of Brain Tumors NCT05571579 · ClinicalTrials.gov ↗ · Brain Tumor Drug: Blood	Observational	Recruiting	2023-11	France
Evaluation of Positron Emission Tomography (PET) With [18F]FET for the Detection of ACTH-Secreting Corticotroph Pituitary Neuroendocrine Tumors. NCT07463625 · ClinicalTrials.gov ↗ · Cushing Disease, ACTH-producing Pituitary Tumour	Observational	Recruiting	2023-11	France
Plaque and Brain Inflammation in Symptomatic Carotid Stenosis: Role of the Ficolin-2 NCT05850247 · ClinicalTrials.gov ↗ · CAROTID STENOSIS	Phase 2	Recruiting	2024-02	France
Study on the Relative Dose Intensity of PARP Inhibitors in Real-life on a Population of Patients Over 70 Years With Advanced Ovarian Cancer NCT06572735 · ClinicalTrials.gov ↗ · Ovarian Cancer Drug: Blood sampling	Observational	Recruiting	2024-09	France
Biocollection of Rare Pediatric-onset of Autoimmune and Autoinflammatory Diseases NCT06435468 · ClinicalTrials.gov ↗ · Systemic Lupus, Autoimmune Diseases, Autoinflammatory Disease	Not applicable	Recruiting	2025-02	France
Genotype/Phenotype Correlation of MORC2 Mutations NCT07038239 · ClinicalTrials.gov ↗ · Charcot Marie Tooth Disease, DIFGAN, Developmental Delay (Disorder)	Observational	Recruiting	2026-06	France
Pregnancy in Women With Rare Multisystemic Vascular Diseases: COGRare5 Study NCT04194619 · ClinicalTrials.gov ↗ · Vascular Anomaly, Osler Rendu Disease, Marfan Syndrome or Related	Observational	Recruiting	2020-02	France
Transplantation After Complete Response In Patients With T-cell Lymphoma NCT05444712 · ClinicalTrials.gov ↗ · Peripheral T Cell Lymphoma	Not applicable	Recruiting	2022-08	France
Attentional Capture by Real-life Episodic Information NCT06934902 · ClinicalTrials.gov ↗ · Healthy Volunteers, Attentional Capture	Not applicable	Recruiting	2026-10	France
Mobile Lung Cancer Screening NCT07015151 · ClinicalTrials.gov ↗ · Lung Cancer Prevention	Observational	Recruiting	2025-06	France
Multimodal Monitoring Study in Neuro Critical Care NCT06900101 · ClinicalTrials.gov ↗ · Subarachnoidal Hemorrhage, Intacranial Hypertension, Acute Trauma Brain Injury	Observational	Recruiting	2020-01	France
CIRculating CANcer MAster-Protocol NCT05089747 · ClinicalTrials.gov ↗ · Adult With Solid Cancer	Observational	Recruiting	2022-12	France
Evaluation of Perfusion and Ventilation Distribution in Children: a Pilot Study. NCT07532811 · ClinicalTrials.gov ↗ · Acute Respiratory Failure	Not applicable	Recruiting	2026-05	France
Feasibility Trial of Extracorporeal Iron Purification in Patients With Myelodysplastic Syndrome or Myelofibrosis NCT06781099 · ClinicalTrials.gov ↗ · Myelodysplastic Syndrome, Myelofibrosis	Not applicable	Recruiting	2026-01	France
CF Organization of Care in the Era of Highly Effective Modulator. NCT06599892 · ClinicalTrials.gov ↗ · Cystic Fibrosis	Observational	Recruiting	2023-09	France
Improvement of Symptoms After Removal of the Essure® Contraceptive Implant NCT06355713 · ClinicalTrials.gov ↗ · Implant Complication, Contraceptive Device; Complications Drug: Blood sample	Not applicable	Recruiting	2025-02	France
Evaluation of the Performance of the IDBIORIV Method in Pathogen Identification and Antibiotic Susceptibility Testing in Patients With Sepsis NCT06219135 · ClinicalTrials.gov ↗ · Sepsis	Observational	Recruiting	2024-03	France
Study of Re-treatment With [177Lu]Lu-PSMA in Men With Metastatic Castration Resistance Prostate Cancer NCT06866938 · ClinicalTrials.gov ↗ · Metastatic Castration-resistant Prostate Cancer Drug: Lu-PSMA	Phase 2	Recruiting	2025-04	France
Effects of Bladder Voiding on Sleep Architecture in Infants NCT04317677 · ClinicalTrials.gov ↗ · Sleep	Not applicable	Recruiting	2020-12	France
Evaluation of the Risk of Cognitive Deficit After Surgery of Epilepsy by Dynamic Spectral Imaging (ISD) of the Cognitive Functions in Patients Explored in StereoElectroEncephaloGraphy (SEEG) NCT03094312 · ClinicalTrials.gov ↗ · Epilepsy	Not applicable	Recruiting	2017-06	France
Long-term Impact of NMDAR Encephalitis, Level 3 NCT07158229 · ClinicalTrials.gov ↗ · NMDAR Autoimmune Encephalitis	Observational	Recruiting	2025-11	France
Study of the Quality of Life in School Aged-children With Posterior Urethral Valves NCT06439862 · ClinicalTrials.gov ↗ · Quality of Life, Posterior Urethral Valve, Renal Insufficiency	Observational	Recruiting	2024-08	France
Attention Modulation of Local and Global Inhibition Mechanisms NCT04279158 · ClinicalTrials.gov ↗ · Optical Phenomena	Not applicable	Recruiting	2022-11	France
Evaluation of Two Surgical Strategies for Robotic Implantation of Total Knee Prostheses (Stryker), Cemented Versus Uncemented NCT04692714 · ClinicalTrials.gov ↗ · Total Knee Arthroplasty	Not applicable	Recruiting	2022-05	France
Multicentric Evaluation of Enhanced Recovery After Surgery Protocol in Adolescent Idiopathic Scoliosis Surgery NCT06908213 · ClinicalTrials.gov ↗ · Idiopathic Scoliosis	Not applicable	Recruiting	2026-09	France
Echocardiographic Analysis by Artificial Intelligence in Hypertension NCT06680986 · ClinicalTrials.gov ↗ · Arterial Hypertension	Observational	Recruiting	2022-06	France
Fine Needle Aspiration (FNA) Evaluation of the Intrahepatic HBV Reservoir and Its Immunological Characteristics in Chronically HBV-infected Patients NCT06047093 · ClinicalTrials.gov ↗ · Chronic Hepatitis b	Not applicable	Recruiting	2024-03	France
Biological Bank for Atrial Fibrillation and Stroke NCT03611816 · ClinicalTrials.gov ↗ · Stroke, Atrial Fibrillation	Observational	Recruiting	2018-04	France
Physical Activity Profile and Sedentary Behaviour in Adults With Cystic Fibrosis NCT06507956 · ClinicalTrials.gov ↗ · Cystic Fibrosis	Observational	Recruiting	2024-09	France
Assessment of the Type I IFN Response in the Nasal Cavity During Respiratory Viral Infections in a Geriatric Department NCT07601412 · ClinicalTrials.gov ↗ · Respiratory Viral Infection	Observational	Recruiting	2024-01	France
Deciphering the Interactions Between Food Intake, Sleepiness, and Nighttime Sleep Quality in Patients With Type 1 Narcolepsy and Idiopathic Hypersomnia NCT06484348 · ClinicalTrials.gov ↗ · Narcolepsy Type 1, Idiopathic Hypersomnia	Not applicable	Recruiting	2024-10	France
Study of microRNAs in a Decompensated Cirrhosis NCT03905746 · ClinicalTrials.gov ↗ · Cirrhosis, Acute Decompensation	Observational	Recruiting	2019-06	France
Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Associated With Systemic Chemotherapy in Women With Advanced Ovarian Cancer NCT04811703 · ClinicalTrials.gov ↗ · Metastatic Ovarian Carcinoma, Peritoneal Carcinomatosis, Stage III Ovarian Cancer	Phase 1	Recruiting	2021-07	France
Evaluation of Tibial Nerve Selective Neurotomy Compared to Botulinum Toxin Injections for Spastic Foot Treatment in Post-stroke Patients According to a Goal-centered Approach NCT05874154 · ClinicalTrials.gov ↗ · Post Stroke Seizure, Spastic Foot Drug: Botulinum toxin	Not applicable	Recruiting	2024-01	France
Autonomous Methadone Delivery System by Nurses NCT07085377 · ClinicalTrials.gov ↗ · Opioid Use Disorder (OUD), Addictology	Not applicable	Recruiting	2025-12	France
Post-operative Analgesic Effect of Oral Nefopam NCT04576078 · ClinicalTrials.gov ↗ · Postoperative Pain After a Total Knee Arthroplasty Drug: Nefopam	Phase 2	Recruiting	2021-06	France
Genetic Predisposition in Cerebral Palsy NCT05317234 · ClinicalTrials.gov ↗ · Cerebral Palsy	Not applicable	Recruiting	2023-09	France
Impact of Nutritional Management on the Frailty of Patients Waiting for Liver Transplantation (Via the LFI Tool) NCT06911619 · ClinicalTrials.gov ↗ · Fragility, Cirrhosis, Hepatic Transplantation	Not applicable	Recruiting	2025-06	France
Early Detection of Type 1 Diabetes NCT06984185 · ClinicalTrials.gov ↗ · Type 1 Diabetes	Observational	Recruiting	2025-11	France
Exploration of Metabolome in Patients With Interstitial Lung Disease and Pulmonary Hypertension With or Without Specific Pulmonary Hypertension Treatment NCT07254338 · ClinicalTrials.gov ↗ · Interstitial Lung Disease, Precapillar Pulmonary Hypertension	Observational	Recruiting	2026-02	France
Validation of the French Version of the New Mobility Score (NMS) NCT07622095 · ClinicalTrials.gov ↗ · Hip Fractures, Mobility Limitation, Independence	Observational	Recruiting	2026-08	France
Control Cohort CTRL COH NCT05370079 · ClinicalTrials.gov ↗ · Parkinson's Disease; Amyotrophic Lateral Sclerosis; Glioblastoma; Cancer Without Neurological Disease; Rheumatoid Polyarthritis	Not applicable	Recruiting	2023-08	France
Evaluation of Integrated Versus Parallel Connection for Renal Replacement Therapy in ECMO Patients NCT06038162 · ClinicalTrials.gov ↗ · Venoarterial Extracorporeal Membrane Oxygenation, Renal Replacement Therapy, Acute Kidney Injury	Not applicable	Recruiting	2024-02	France
Assessment of Blood Viscosity in ARDS (Acute Respiratory Distress Syndrome) NCT07823296 · ClinicalTrials.gov ↗ · ARDS	Observational	Recruiting	2026-10	France
Brain Mechanisms of Social Perception in Parkinson's Disease NCT06884722 · ClinicalTrials.gov ↗ · Social Perception in Parkinson's Disease	Not applicable	Recruiting	2025-07	France
Avelumab and Methotrexate in in Low-risk Gestational Trophoblastic Neoplasias as First Line Treatment NCT04396223 · ClinicalTrials.gov ↗ · Gestational Trophoblastic Neoplasias (GTN) Drug: Avelumab	Phase 1/2	Recruiting	2020-02	France
PSYLIVER-PILOTE: Involvement of the Autonomic Nervous System in Hepatocellular Carcinoma (HCC) NCT07393074 · ClinicalTrials.gov ↗ · Hepato Cellular Carcinoma, Cirrhosis, Autonomic Nervous System	Not applicable	Recruiting	2026-04	France
Characterization of the IFN-I Response in Subjects Who Experienced Severe or Mild Forms of COVID-19 NCT06703034 · ClinicalTrials.gov ↗ · COVID-19	Not applicable	Recruiting	2024-12	France
Neurodevelopmental Disorder Diagnosis During Adulthood NCT06691048 · ClinicalTrials.gov ↗ · Neurodevelopmental Disorders	Observational	Recruiting	2024-01	France
Eco-anxiety and Suicide NCT05707975 · ClinicalTrials.gov ↗ · Suicide, Suicide Attempt, Suicidal	Observational	Recruiting	2023-04	France
Quality of Information Provided During Antenatal Consultations NCT06820892 · ClinicalTrials.gov ↗ · Congenital Anomalies, Prematurity, Antenatal Consultation	Observational	Recruiting	2024-08	France
Cultured Autologous Oral Mucosa Epithelial Sheet for the Treatment of Bilateral Limbal Stem Cell Deficiency NCT03949881 · ClinicalTrials.gov ↗ · Total Bilateral Limbal Cell Deficiency	Phase 1/2	Recruiting	2020-11	France
TTV-based mAnagement Of Long-term ImmunosuppreSsion in Kidney Transplantation NCT06829719 · ClinicalTrials.gov ↗ · Infection, Cancer, Rejection Drug: Biological tests	Not applicable	Recruiting	2025-04	France
Randomized, Single-blind Pilot Study Assessing the Effect of Cutaneous RESonance Stimulation SYMPAthetic and Parasympathetic Tone and Anxiety in Patients Admitted for Cardiac Surgery NCT07070986 · ClinicalTrials.gov ↗ · Anxiety	Observational	Recruiting	2025-09	France
Study of Sleep Quality and Its Specific Determinants During the Care Pathway of a Liver Transplant Patient NCT07674355 · ClinicalTrials.gov ↗ · Liver Transplantation	Observational	Recruiting	2026-10	France
Evaluation of EXL01, a New Live Biotherapeutic Product to Prevent Recurrence of Clostridioides Difficile Infection in High-risk Patients NCT06306014 · ClinicalTrials.gov ↗ · Clostridioides Difficile Infection, Recurrent Infection Drug: EXL01	Phase 1/2	Recruiting	2024-05	France
Evaluation Patient Satisfaction After Passive Bladder Catheter Removal Compared to Active Removal NCT05313945 · ClinicalTrials.gov ↗ · Urologic Diseases	Not applicable	Recruiting	2022-07	France
Oro-myofunctional Characteristics and Obstructive Sleep Apnea in Infants With Down Syndrome NCT07195253 · ClinicalTrials.gov ↗ · Obstructive Sleep Apnea, Down Syndrome (Trisomy 21)	Observational	Recruiting	2026-04	France
Links Between Epileptic Activity, Sleep Disruption and Mental Content During Sleep NCT07605858 · ClinicalTrials.gov ↗ · Patients With Drug-resistant Focal Epilepsy, SEEG as Part of Presurgical Evaluation	Observational	Recruiting	2026-06	France
Impact of Epilepsy on the Brainstem Adenosine Pathway and Its Relation With Arousal and Respiratory Reactivity NCT07249034 · ClinicalTrials.gov ↗ · Epilepsy, Drug-resistant Focal Epilepsy, Healthy Controls	Not applicable	Recruiting	2026-10	France
Neural Bases of Motivation NCT07251816 · ClinicalTrials.gov ↗ · Healthy Volunteers, Motivation, Action	Not applicable	Recruiting	2026-01	France
Impact of a Multi-infusion Strategy in Neonatology on the Rate of Central Line-associated Bloodstream Infections NCT06656104 · Neonatal Infection	Observational	Recruiting	2025-01	France
Monitoring of Anti-TFPI in Hemophilia NCT07101926 · ClinicalTrials.gov ↗ · Hemophilia, Rebalancing Agents, Prophylaxis Drug: Blood sampling	Observational	Recruiting	2025-10	France
Evaluation of the Impact of a Paramedical Training Program for Nurses and Nursing Assistants on the Length of Stay and Prevention of Hospital Iatrogenic Complications in Elderly Patients NCT05936515 · ClinicalTrials.gov ↗ · Iatrogenesis	Observational	Recruiting	2023-05	France
MEG Versus EEG HR for the Localization of the Epileptogenic Zone as Part of the Pre-surgical Assessment of Epilepsy NCT03893916 · Drug-resistant Epilepsy, Candidates for Surgical Treatment, Epilepsy	Not applicable	Recruiting	2019-10	France
Characterization of New Phenotypes of Patients With Spinal Muscular Atrophy Treated With SMN Restoring Therapy NCT06321965 · ClinicalTrials.gov ↗ · Spinal Muscular Atrophy Drug: Biocollection	Not applicable	Recruiting	2024-07	France
Developmental Coordination Disorder NCT05154799 · ClinicalTrials.gov ↗ · Motor Skills Disorders, Neurodevelopmental Disorders	Not applicable	Recruiting	2021-12	France
Validation of the French Version of the OSA-18 Questionnaire NCT07136909 · ClinicalTrials.gov ↗ · Apnea, Obstructive	Observational	Recruiting	2026-06	France
Immunological Effects of Iron Supplementation in HHT Disease NCT07111598 · ClinicalTrials.gov ↗ · Hereditary Haemorrhagic Telangiectasia	Not applicable	Recruiting	2025-09	France
Tongue Muscular Assessment in Children With Sleep Disordered Breathing NCT07273019 · ClinicalTrials.gov ↗ · Obstructive Sleep Apnea	Not applicable	Recruiting	2026-03	France
Hydroxychloroquine as a Steroid-sparing Agent in Extrapulmonary Sarcoidosis NCT05841758 · ClinicalTrials.gov ↗ · Sarcoidosis, Pulmonary Drug: Hydroxychloroquine	Phase 4	Recruiting	2024-07	France
Evaluation of the Impact of an Individual Peer Support Intervention for Stroke Patients When Returning Home: a Mixed Methods Pilot Study NCT04197258 · ClinicalTrials.gov ↗ · Stroke	Not applicable	Recruiting	2020-10	France

Showing the 100 most recently updated of 382 trials (recruiting first). The rest are in the country registers linked in each row.

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

Hospices Civils de Lyon in the EU trials register (CTIS)

5 trials

Authorised or ongoing trials in the EU Clinical Trials Information System with Hospices Civils de Lyon as sponsor. Some are the same study as a ClinicalTrials.gov record above; the two registries share no common ID. Trials with a site in Ireland are listed first.

Study	Phase	Status	Countries
[68]GA-FAPI-46 PET/CT for the diagnosis of metastatic lesions in patients with lobular breast cancer (ICL). FAPICL 2025-524897-40-00 · Diagnosis Drug: [68Ga]Ga-FAPI-46	Phase 2	Authorised	France
PITALC. Pilot study on the effect of PITAC (Pressurized IntraThoracic Aerosol Chemotherapy) by videothoracoscopy in patients with malignant pleural effusion in the light of the results of a retrospective historical cohort treated with talc pleurodesis by videothoracoscopy 2025-523482-23-00 · Neoplasms	Phase 2	Authorised	France
Immunogenicity and safety of two respiratory syncytial virus vaccine strategies in lung and allogeneic haematopoietic stem cell transplant recipients: A phase 2 trial RSVaxID 2025-524374-42-00 · Surgical Procedures, Operative Drug: Vaxzevria	Phase 2	Authorised	France
ADRESS : Efficacy of the Alpha 2 agonist dexmedetomidine for sympathetic Deactivation in REfractory Septic Shock: a randomized, controlled trial 2025-524122-18-00 · CTIS ↗ · Not possible to specify Drugs: Hydrocortisone, Midazolam, Norepinephrine	Phase 3	Ongoing	France
Efficacy of prophylactic levetiracetam for improving functional outcome in the acute phase of intracerebral haemorrhage: a randomised, double-blind, placebo-controlled, phase 3 trial PEACH 2 2024-515663-59-00 · CTIS ↗ · Nervous System Diseases Drug: Levetiracetam	Phase 3	Authorised	France

Drugs in Hospices Civils de Lyon trials

36 compounds

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

Conditions in Hospices Civils de Lyon trials

574 conditions

Epilepsy10 Cancer10 Healthy Volunteers6 Cirrhosis6 Breast Cancer6 Stroke5 Obstructive Sleep Apnea5 Acute Kidney Injury3 Ovarian Cancer3 Prostate Cancer3Down Syndrome (Trisomy 21)3Lung Cancer3 Melanoma3 Crohn Disease3Dravet Syndrome2Fragile X Syndrome (FXS)2Kidney Transplantation2 Endometriosis2Drug Resistant Epilepsy2Healthy Controls2Paraneoplastic Neurological Syndrome2Autoimmune Encephalitis2Ischemic Stroke2Genetic Disease2

By trial register

Register	Trials	Recruiting
Clinical trials in France	382	250
Clinical trials in Belgium	2	1
Clinical trials in India	1	1
Clinical trials in Israel	1	1
Clinical trials in Germany	1	0
Clinical trials in Egypt	1	0
Clinical trials in Italy	1	1
EU register (CTIS)	5	—

A trial with sites in more than one country appears in each of those registers; recruiting counts cover the trials listed on this page.

Other sponsors in Epilepsy

Sponsor	Trials
Fondation Ophtalmologique Adolphe de Rothschild	6
Rapport Therapeutics	4
University Hospital, Toulouse	4
Assistance Publique Hopitaux De Marseille	3
IRCCS National Neurological Institute "C. Mondino" Foundation	3
IRCCS Eugenio Medea	3
Aziende Chimiche Riunite Angelini Francesco	2
NaviFUS Corporation	2
Shen Chun-Hong	2
Sahlgrenska University Hospital	2

Sponsors with the most current trials registered for this condition.

Questions about Hospices Civils de Lyon trials

How many clinical trials does Hospices Civils de Lyon sponsor?

Hospices Civils de Lyon is the lead sponsor of 382 current trials on ClinicalTrials.gov in our France, Belgium, India, Israel, Germany, Egypt and Italy registers, and 5 authorised or ongoing trials in the EU register (CTIS), as of the registry sync on 10 November 2026. Completed and withdrawn studies are not counted.

Are Hospices Civils de Lyon trials recruiting?

Yes. 264 of its 382 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is Hospices Civils de Lyon testing?

Its current trials name 36 drugs and biologicals as interventions. The most frequent are Blood sampling (8), Biocollection (4), Blood sample (4), Domvanalimab (2) and Zimberelimab (2). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 10 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.